What is Resistance?

Mutations & Resistance in HIV

Managing Resistance to HIV Therapy

Resistance Quiz

References

Credits

References for Resistance

Next

1. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117 - 122.
   
   
2. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123 - 126.
   
   
3. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 1995; 267: 483 - 489.
   
   
4. Kunzi MS, Groopman JE. Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells. Blood 1993; 81: 3336 - 3342.
   
   
5. Connor RI, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994; 68: 4400 - 4408.
   
   
6. Mohri H, Singh MK, Ching WTW, Ho DD. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Proc Natl Acad Sci USA 1993; 90: 25 - 29.
   
   
7. N�jera I, Richman DD, Olivares I, et al. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Res Hum Retroviruses 1994; 10: 1479 - 1488.
   
   
8. N�jera I, Holgu�n A, Qui�ones-Mateu E, et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol 1995; 69: 23 - 31.
   
   
9. Frost SDW, McLean AR. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection. AIDS 1994; 8: 323 - 332.
   
   
10. Kellam P, Boucher CAB, Tijnagal JMGH, Larder BA. Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance. J Gen Virol 1994; 75: 341 - 351.
    
    
11. Cleland A, Watson HG, Robertson P, Ludlam CA, Leigh Brown AJ. Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients. J ACQUIR HUM IMMUNE DEFIC SYNDR HUM RETROVIRUSS 1996;12;6-18
    
    
12. BHIVA Guidelines Co-ordinating Committee. British HIV association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997;349:1086-1092.
    
13. Rooke R, Tremblay M, Soudeyns H, et al. Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. AIDS 1989; 3: 411 - 415.
    
    
14. Albert J, Wahlberg J, Lundeberg J, et al. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in post-treatment sera. J Virol 1992; 66:5627 - 5630.
    
    
15. Condra JH, Schleif WA, Blahy OM, et al. Evidence for the existence of long-lived genetic reservoirs of HIV-1 in infected patients. 4th International HIV drug-resistance Workshop, Sardinia, 1995; Abstract 82.